About
Advance every cancer decision.
Listed competitors
Also in this space
Leveraging the adaptive immune system to diagnose and treat disease.
Shares Biotech, HealthTech
Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.
Shares Biotech, HealthTech
AI-powered platform for personalized cell therapy development and manufacturing.
Shares Biotech, HealthTech
PFx Biotech is developing a novel platform for the discovery and development of protein-based therapeutics.
Shares Biotech, Drug Discovery
Biosynthesis of cannabinoids and psychedelics using advanced biotechnology.
Shares Biotech, Drug Discovery
AI-powered platform for antibody discovery and development to create new medicines.
Shares Biotech, Drug Discovery
Key facts
- Website
- triomics.com
- Headquarters
- Cambridge, United States
- Founded
- 2021
- Employees
- 67
- Total funding
- $22M (Series B)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 15 Jan 2024 | Series B | $22M |
Tech stack
Detected on triomics.com, last scanned 18 Oct 2026. Run your own scan
- CMS / Builders
- Webflow
- CDN
- Cloudflare
Triomics scores 44. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
Is Triomics trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Triomics is 81 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Triomics raised?
Triomics has raised a total of $22M in funding. The most recent round on record is Series B.
How many employees does Triomics have?
Triomics has approximately 67 people on record.
